Crinetics Pharmaceuticals (CRNX) P/E (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) P/E from Oct 1, 2018 to Jul 20, 2026. The TTM Crinetics Pharmaceuticals (CRNX) P/E is -16.43. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Crinetics Pharmaceuticals (CRNX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -16.43 | +73.85% |
| 2025 | -9.45 | -33.38% |
| 2024 | -14.19 | +38.80% |
| 2023 | -10.22 | +64.19% |
| 2022 | -6.23 | -39.65% |
| 2021 | -10.32 | +76.91% |
| 2020 | -5.83 | -51.58% |
| 2019 | -12.04 | -73.15% |
| 2018 | -44.85 | N/A |
Comparison Crinetics Pharmaceuticals (CRNX) P/E with competitors
Crinetics Pharmaceuticals (CRNX) P/E is -16.43.